Brokerages Set Heartflow, Inc. (NASDAQ:HTFL) Price Target at $43.43

Heartflow, Inc. (NASDAQ:HTFL) has earned an average recommendation of “Moderate Buy” from the twelve ratings firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, eight have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $43.4286.

Several equities research analysts have recently commented on HTFL shares. Benchmark restated a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. JPMorgan Chase & Co. increased their price objective on Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. Weiss Ratings upgraded shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. Robert W. Baird set a $45.00 price objective on Heartflow in a research note on Friday, August 14th. Finally, Canaccord Genuity Group increased their target price on Heartflow from $37.00 to $45.00 and gave the company a “buy” rating in a research note on Friday, August 14th.

Insider Transactions at Heartflow

In other Heartflow news, CEO John C.M. Farquhar sold 32,676 shares of Heartflow stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $45.00, for a total transaction of $1,470,420.00. Following the transaction, the chief executive officer directly owned 388,044 shares in the company, valued at approximately $17,461,980. The trade was a 7.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of Heartflow stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $41.23, for a total value of $380,099.37. Following the transaction, the insider owned 86,459 shares in the company, valued at $3,564,704.57. This trade represents a 9.64% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 164,041 shares of company stock valued at $5,727,636. 7.70% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Heartflow

Several institutional investors have recently added to or reduced their stakes in the stock. XXEC Inc. bought a new stake in shares of Heartflow in the second quarter valued at about $2,524,764,000. Sei Investments Co. boosted its holdings in shares of Heartflow by 342.5% in the 1st quarter. Sei Investments Co. now owns 67,048 shares of the company’s stock valued at $1,631,000 after buying an additional 51,895 shares during the last quarter. Quantinno Capital Management LP bought a new position in shares of Heartflow in the 1st quarter valued at about $1,734,000. Handelsbanken Fonder AB bought a new position in Heartflow during the second quarter worth about $910,000. Finally, Walleye Capital LLC bought a new position in shares of Heartflow during the 2nd quarter worth approximately $8,760,000.

Heartflow Price Performance

HTFL opened at $50.20 on Tuesday. The firm’s fifty day moving average price is $31.00 and its two-hundred day moving average price is $28.47. Heartflow has a fifty-two week low of $20.13 and a fifty-two week high of $50.85. The company has a market capitalization of $4.37 billion and a P/E ratio of -27.43.

Heartflow (NASDAQ:HTFL) last posted its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business had revenue of $64.08 million for the quarter. Heartflow’s quarterly revenue was up 47.7% compared to the same quarter last year. On average, equities research analysts expect that Heartflow will post -0.82 EPS for the current fiscal year.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.